Comparison

LIPI Blocking Peptide (Center)

Item no. ABC-BP20877a
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Lyophilized
Specific against other
Citations Hiramatsu T.,et al.J. Biol. Chem. 278:49438-49447(2003).
Wen X.-Y.,et al.Hum. Mol. Genet. 12:1131-1143(2003).
Hattori M.,et al.Nature 405:311-319(2000).
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Lipase member I,LIPI,311-,Cancer/testis antigen 17,CT17,LPD lipase,Membrane-associated phosphatidic acid-selective phospholipase A1-beta,mPA-PLA1 beta,LIPI,LPDL
Similar products LIPI, CT17, LPDL, Lipase member I, Membrane-associated phosphatidic acid-selective phospholipase A1-beta, mPA-PLA1 beta, LPD lipase, Cancer/testis antigen 17, 311-
Available
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence is selected from aa 224-238 of HUMAN LIPI
Bio Background
Hydrolyzes specifically phosphatidic acid (PA) to produce 2-acyl lysophosphatidic acid (LPA; a potent bioactive lipid mediator) and fatty acid. Does not hydrolyze other phospholipids, like phosphatidylserine (PS), phosphatidylcholine (PC) and phosphatidylethanolamine (PE) or triacylglycerol (TG).
Gene Name
LIPI
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close